Nutritional assessment and treatment management of infantile cholestatic liver disease

Lina DU; Lulu XIA; Jie YAN; Ziyun GUO; Yan YANG

doi:10.3969/j.issn.1001-5256.2022.01.041

Volume 38 Issue 1

Jan. 2022

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2022 > 38(1): 228-232

PDF( 1989 KB)

Nutritional assessment and treatment management of infantile cholestatic liver disease

DOI: 10.3969/j.issn.1001-5256.2022.01.041

Lina DU^a,
Lulu XIA^b,
Jie YAN^b,
Ziyun GUO^a,
Yan YANG^{a
,
,}

a.
National Center for Children's Health, Department of Traditional Chinese Medicine, Capital Medical University, Beijing 100045, China
b.
National Center for Children's Health, Department of Clinical Nutrition, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China

Research funding:

Scientific Research Projects of China Medical Association of Minorities (2020ZY278-400403);

Bejing Municipal Administration of Hospital Incubating Program (PZ2022027)

Received Date: 2021-05-06
Accepted Date: 2021-07-28
Published Date: 2022-01-20

Abstract

Abstract

Children with infantile cholestatic liver disease are often accompanied by malnutrition, which in turn can affect its progression and prognosis. There are many factors causing malnutrition and various methods for malnutrition assessment, but there is still a lack of uniform standard for nutritional assessment in patients with liver diseases, and a variety of indicators and methods are required for comprehensive analysis and assessment. This article analyzes the common causes of malnutrition in children with cholestatic liver disease, introduces the different methods for nutritional assessment, including anthropometric measurements, laboratory examination, and nutritional assessment tools, and elaborates on nutritional intervention treatment, so as to improve the understanding of nutritional problems in children with cholestatic liver disease. Early identification and rational interventions can help to improve the quality of life and prognosis of children.
- Cholestasis, Intrahepatic,
- Nutrition Assessment,
- Therapeutics

FullText(HTML)

References(40)

References

[1]	MARTÍNEZ-UÑA M, LÓPEZ-MANCHEÑO Y, DIÉGUEZ C, et al. Unraveling the role of leptin in liver function and its relationship with liver diseases[J]. Int J Mol Sci, 2020, 21(24): 9368. DOI: 10.3390/ijms21249368.
[2]	SANTETTI D, DE ALBUQUERQUE WILASCO MI, DORNELLES CT, et al. Serum proinflammatory cytokines and nutritional status in pediatric chronic liver disease[J]. World J Gastroenterol, 2015, 21(29): 8927-8934. DOI: 10.3748/wjg.v21.i29.8927.
[3]	PLAUTH M, BERNAL W, DASARATHY S, et al. ESPEN guideline on clinical nutrition in liver disease[J]. Clin Nutr, 2019, 38(2): 485-521. DOI: 10.1016/j.clnu.2018.12.022.
[4]	KELLY DA, PROTEROE S, CLARKE S. Acute and chronic liver disease[M]// In Nutrition in Pediatrics. 5th ed. USA: People's Medical Publishing House-USA, 2016: 851-863.
[5]	GHUFRAN A. Nutrition in chronic liver disease: A point-of-care review[J]. Nutr Clin Pract, 2020, 35(2): 211-217. DOI: 10.1002/ncp.10470.
[6]	BONEFELD K, MØLLER S. Insulin-like growth factor-I and the liver[J]. Liver Int, 2011, 31(7): 911-919. DOI: 10.1111/j.1478-3231.2010.02428.x.
[7]	BECKER P, CARNEY LN, CORKINS MR, et al. Consensus statement of the Academy of Nutrition and Dietetics/American Society for Parenteral and Enteral Nutrition: Indicators recommended for the identification and documentation of pediatric malnutrition (undernutrition)[J]. Nutr Clin Pract, 2015, 30(1): 147-161. DOI: 10.1177/0884533614557642.
[8]	NORMATOV I, KAPLAN S, AZZAM RK. Nutrition in pediatric chronic liver disease[J]. Pediatr Ann, 2018, 47(11): e445-e451. DOI: 10.3928/19382359-20181022-03.
[9]	FABIANSEN C, PHELAN K, CICHON B, et al. Short malnourished children and fat accumulation with food supplementation[J]. Pediatrics, 2018, 142(3): e20180679. DOI: 10.1542/peds.2018-0679.
[10]	STEPHENS K, ORLICK M, BEATTIE S, et al. Examining mid-upper arm circumference malnutrition z-score thresholds[J]. Nutr Clin Pract, 2020, 35(2): 344-352. DOI: 10.1002/ncp.10324.
[11]	GAO F, ZHANG WQ, LIANG SQ, et al. Application of serum albumin, prealbumin and transferrin in the evaluation of nutritional support for patients with chronic liver failure[J]. J Pract Med, 2017, 33(4): 603-605. DOI: 10.3969/j.issn.1006-5725.2017.04.027. 高飞, 张卫青, 梁首勤, 等. 血清白蛋白、前白蛋白和转铁蛋白在评价慢性肝衰竭患者营养支持中的应用[J]. 实用医学杂志, 2017, 33(4): 603-605. DOI: 10.3969/j.issn.1006-5725.2017.04.027.
[12]	DASARATHY S. Myostatin and beyond in cirrhosis: All roads lead to sarcopenia[J]. J Cachexia Sarcopenia Muscle, 2017, 8(6): 864-869. DOI: 10.1002/jcsm.12262.
[13]	MEDHAT AS, AHMED AO, AHMED FT, et al. Creatinine height index as a predictor of nutritional status among patients with liver cirrhosis[J]. J Public Health Epidemiol, 2016, 8(10): 220-228. DOI: 10.5897/JPHE2016.0850.
[14]	RABITO EI, MARCADENTI A, DA SILVA FINK J, et al. Nutritional risk screening 2002, short nutritional assessment questionnaire, malnutrition screening tool, and malnutrition universal screening tool are good predictors of nutrition risk in an emergency service[J]. Nutr Clin Pract, 2017, 32(4): 526-532. DOI: 10.1177/0884533617692527.
[15]	MCCARTHY H, MCNULTY H, DIXON M, et al. Screening for nutrition risk in children: The validation of a new tool[J]. J Hum Nutr Diet, 2008, 21(4): 395-396. DOI: 10.1111/j.1365-277X.2008.00881_31.x.
[16]	REED M, MULLANEY K, RUHMANN C, et al. Screening tool for the assessment of malnutrition in pediatrics (STAMP) in the electronic health record: A validation study[J]. Nutr Clin Pract, 2020, 35(6): 1087-1093. DOI: 10.1002/ncp.10562.
[17]	GERASIMIDIS K, KEANE O, MACLEOD I, et al. A four-stage evaluation of the Paediatric Yorkhill Malnutrition Score in a tertiary paediatric hospital and a district general hospital[J]. Br J Nutr, 2010, 104(5): 751-756. DOI: 10.1017/S0007114510001121.
[18]	HULST JM, ZWART H, HOP WC, et al. Dutch national survey to test the STRONGkids nutritional risk screening tool in hospitalized children[J]. Clin Nutr, 2010, 29(1): 106-111. DOI: 10.1016/j.clnu.2009.07.006.
[19]	MACIEL J, NAKANO EY, CARVALHO K, et al. STRONGkids validation: Tool accuracy[J]. J Pediatr (Rio J), 2020, 96(3): 371-378. DOI: 10.1016/j.jped.2018.12.012.
[20]	RIPKA WL, ORSSO CE, HAQQ AM, et al. Lean mass reference curves in adolescents using dual-energy x-ray absorptiometry (DXA)[J]. PLoS One, 2020, 15(2): e0228646. DOI: 10.1371/journal.pone.0228646.
[21]	SCHMIDT SC, BOSY-WESTPHAL A, NIESSNER C, et al. Representative body composition percentiles from bioelectrical impedance analyses among children and adolescents. The MoMo study[J]. Clin Nutr, 2019, 38(6): 2712-2720. DOI: 10.1016/j.clnu.2018.11.026.
[22]	KIGARU D, NDUNG'U ZW, MACHARIA-MUTIE CW. Application of stable isotope dilution techniques to assess body fat and comparison with WHO BMI-for-age classification as a measure of obesity among schoolchildren in Nairobi, Kenya[J]. Public Health Nutr, 2021, 24(12): 3587-3591. DOI: 10.1017/S1368980020001950.
[23]	BECKER PJ, GUNNELL BELLINI S, WONG VEGA M, et al. Validity and reliability of pediatric nutrition screening tools for hospital, outpatient, and community settings: A 2018 evidence analysis center systematic review[J]. J Acad Nutr Diet, 2020, 120(2): 288-318. e2. DOI: 10.1016/j.jand.2019.06.257.
[24]	GONG ST. Nutritional treatment of infantile cholestatic liver disease[J]. Chin J Pract Pediatr, 2013, 28(4): 258-260. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSEK201304008.htm 龚四堂. 婴儿胆汁淤积性肝病营养治疗[J]. 中国实用儿科杂志, 2013, 28(4): 258-260. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSEK201304008.htm
[25]	WU MC, MENG QH. Nutritional assessment and clinical management of patients with acute-on-chronic liver failure[J]. J Clin Hepatol, 2021, 37(4): 770-774. DOI: 10.3969/j.issn.1001-5256.2021.04.006. 吴牧晨, 孟庆华. 慢加急性肝衰竭患者的营养评估及临床管理[J]. 临床肝胆病杂志, 2021, 37(4): 770-774. DOI: 10.3969/j.issn.1001-5256.2021.04.006.
[26]	CHEN X, WANG J, LU Y, et al. Feeding practices in 6-24-month-old children with chronic cholestatic liver diseases: A mixed-method study[J]. BMC Pediatr, 2020, 20(1): 395. DOI: 10.1186/s12887-020-02290-8.
[27]	YANG CH, PERUMPAIL BJ, YOO ER, et al. Nutritional needs and support for children with chronic liver disease[J]. Nutrients, 2017, 9(10): 1127. DOI: 10.3390/nu9101127.
[28]	IQBAL U, JADEJA RN, KHARA HS, et al. A comprehensive review evaluating the impact of protein source (vegetarian vs. meat based) in hepatic encephalopathy[J]. Nutrients, 2021, 13(2): 370. DOI: 10.3390/nu13020370.
[29]	GLUUD LL, DAM G, LES I, et al. Branched-chain amino acids for people with hepatic encephalopathy[J]. Cochrane Database Syst Rev, 2017, 5: CD001939. DOI: 10.1002/14651858.CD001939.pub4.
[30]	HAMED A, HAMED A, LAMBERT K. Branched-chain amino acids for people with hepatic encephalopathy[J]. Am Fam Physician, 2020, 101(1): Online. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481897/
[31]	SHNEIDER BL, MAGEE JC, KARPEN SJ, et al. Total serum bilirubin within 3 months of hepatoportoenterostomy predicts short-term outcomes in biliary atresia[J]. J Pediatr, 2016, 170: 211-217. e1-e2. DOI: 10.1016/j.jpeds.2015.11.058.
[32]	VENKAT VL, SHNEIDER BL, MAGEE JC, et al. Total serum bilirubin predicts fat-soluble vitamin deficiency better than serum bile acids in infants with biliary atresia[J]. J Pediatr Gastroenterol Nutr, 2014, 59(6): 702-707. DOI: 10.1097/MPG.0000000000000547.
[33]	YILMAZ O, DALY A, PINTO A, et al. Natural protein tolerance and metabolic control in patients with hereditary tyrosinaemia type 1[J]. Nutrients, 2020, 12(4): 1148. DOI: 10.3390/nu12041148.
[34]	VAN SPRONSEN FJ, VAN RIJN M, MEYER U, et al. Dietary considerations in tyrosinemia type I[J]. Adv Exp Med Biol, 2017, 959: 197-204. DOI: 10.1007/978-3-319-55780-9_18.
[35]	ROSS KM, FERRECCHIA IA, DAHLBERG KR, et al. Dietary management of the glycogen storage diseases: Evolution of treatment and ongoing controversies[J]. Adv Nutr, 2020, 11(2): 439-446. DOI: 10.1093/advances/nmz092.
[36]	KISHNANI PS, AUSTIN SL, ABDENUR JE, et al. Diagnosis and management of glycogen storage disease type I: A practice guideline of the American College of Medical Genetics and Genomics[J]. Genet Med, 2014, 16(11): e1. DOI: 10.1038/gim.2014.128.
[37]	WELLING L, BERNSTEIN LE, BERRY GT, et al. International clinical guideline for the management of classical galactosemia: Diagnosis, treatment, and follow-up[J]. J Inherit Metab Dis, 2017, 40(2): 171-176. DOI: 10.1007/s10545-016-9990-5.
[38]	HAYASAKA K. Metabolic basis and treatment of citrin deficiency[J]. J Inherit Metab Dis, 2021, 44(1): 110-117. DOI: 10.1002/jimd.12294.
[39]	TRAN C. Inborn errors of fructose metabolism. What can we learn from them?[J]. Nutrients, 2017, 9(4): 356. DOI: 10.3390/nu9040356.
[40]	DI DATO F, SPADARELLA S, PUOTI MG, et al. Daily fructose traces intake and liver injury in children with hereditary fructose intolerance[J]. Nutrients, 2019, 11(10): 2397. DOI: 10.3390/nu11102397.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (493) PDF downloads(47)

Nutritional assessment and treatment management of infantile cholestatic liver disease

DOI: 10.3969/j.issn.1001-5256.2022.01.041

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Nutritional assessment and treatment management of infantile cholestatic liver disease

DOI: 10.3969/j.issn.1001-5256.2022.01.041

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content